In vitro comparison of Pulmicort Respules™ with Clenil® pro aerosol in combination with three nebulisers

A. Vaghi, E. Berg, S. Liljedahl, J. O. Svensson (Garbagnate, Italy; Lund, Sweden)

Source: Annual Congress 2002 - Asthma - Therapy and management -1
Session: Asthma - Therapy and management -1
Session type: Thematic Poster Session
Number: 376
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Vaghi, E. Berg, S. Liljedahl, J. O. Svensson (Garbagnate, Italy; Lund, Sweden). In vitro comparison of Pulmicort Respules™ with Clenil® pro aerosol in combination with three nebulisers. Eur Respir J 2002; 20: Suppl. 38, 376

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of two budesonide powder inhalers, Giona Easyhaler® and Pulmicort Turbuhaler® in steroid-naive asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 100s
Year: 2001

Flutide™ Diskus™ less consistent than Pulmicort® Turbuhaler® with respect to in vitro fine particle dose proportionality
Source: Eur Respir J 2001; 18: Suppl. 33, 157s
Year: 2001

Chemical compatibility of budesonide inhalation suspension (Pulmicort Respules™) with other nebulization products
Source: Eur Respir J 2001; 18: Suppl. 33, 121s
Year: 2001

Beclometasone/formoterol administered via extrafine dry powder inhaler in controlled asthmatic patients: Comparison with pMDI and beclometasone monotherapy
Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma
Year: 2012


Does Clickhaler match the Turbuhaler for efficacy of inhaled budesonide?
Source: Eur Respir J 2005; 26: Suppl. 49, 339s
Year: 2005

Pharmacokinetic and pharmacodinamic effect of AeroChamber Plus spacer on the Extrafine beclometasone dipropionate plus formoterol combination (200/6 µg)
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010

Comparison of the efficacy and safety of budesonide administered via Clickhaler® or Turbuhaler®
Source: Eur Respir J 2003; 22: Suppl. 45, 311s
Year: 2003

Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Bronchodilator response to salbutamol administered through metered-dose inhaler plus spacer or dry-powder inhaler in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Efficacy, safety and cost of budesonide/formoterol in a single inhaler compared with budesonide plus formoterol as separate inhalers
Source: Eur Respir J 2002; 20: Suppl. 38, 43s
Year: 2002

Assessment of relative potency of salbutamol administered via a metered-dose inhaler plus spacer or via a dry-powder inhaler in asthma patients
Source: Eur Respir J 2006; 28: Suppl. 50, 209s
Year: 2006

Lung deposition of formoterol in COPD patients: comparison of formoterol HFA pMDI, and formoterol dry powder inhaler
Source: Eur Respir J 2007; 30: Suppl. 51, 100s
Year: 2007

Fine particle mass of salbutamol: diskus and turbuhaler in vitro compared
Source: Eur Respir J 2002; 20: Suppl. 38, 499s
Year: 2002

Pharmaceutical development of salmeterol HFA metered dose inhaler
Source: Eur Respir J 2004; 24: Suppl. 48, 582s
Year: 2004

Demonstration of therapeutic equivalence between Salmeterol/fluticasone Easyhaler and Seretide Diskus
Source: International Congress 2017 – Inhalers and their use
Year: 2017


Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Efficacy and safety of budesonide/formoterol fumarate dihydrate metered dose inhaler (BFF MDI) using co-suspension delivery technology compared to monocomponents and an active comparator in COPD
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018


The novel budesonide HFA pMDI is clinically comparable to the conventional budesonide CFC pMDI in paediatric patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 160s
Year: 2005

A comparison of the efficacy of salmeterol/fluticasone propionate combination (SF) with beclometasone dipropionate (BDP) delivered via metered dose inhaler (MDI) in patients not well controlled on bronchodilators alone
Source: Eur Respir J 2001; 18: Suppl. 33, 53s
Year: 2001

Improved delivery of fenoterol plus ipratropium bromide using Respimat(R) compared with a conventional metered dose inhaler
Source: Eur Respir J 2001; 17: 225-232
Year: 2001